Permanent Hepatic Artery Ligation Versus Temporary Dearterialization in the Treatment of Hepatic Tumors

  • S. Bengmark
  • B. Jeppsson
Conference paper
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 100)

Abstract

The rationale for treating liver tumors by occlusion therapy is based on the derivation of the nutrition of liver tumors from the hepatic artery. Vascularity of malignant neoplasms in the liver has been investigated by many authors. Breedis and Young [10] studied the tumor circulation of experimental liver neoplasms and autopsy specimens of patients, using various dyes, gelatin, and vinyl acetate for injections into hepatic arteries and veins. Dye was demonstrated within the tumors after hepatic artery injections, but only in the periphery after the portal injection. The authors estimated that 80%–100% of the human liver tumor circulation was derived from the hepatic artery. Blanchard et al. [9] used isotope-labeled microspheres injected into the hepatic artery and portal vein in rabbits with implanted liver tumors. They found a tumor/liver ratio of 4.2 after hepatic artery injection, but only 0.3 after injection into the portal vein. Nilsson and Zettergren [22] investigated primary hepatic carcinoma induced in rats by injecting barium sulfate and formalin into hepatic vessels and used an X-ray technique to visualize vascular penetration of the tumors. In some neoplasms the contrast material from the portal vein filled vessels resembling sinusoids, although the main filling occurred from the hepatic artery. Around the periphery of the tumor a zone of vessels was filled with contrast material from the portal vein. In a series of studies, Ackerman [1] examined the blood supply of experimental liver metastases. Using isotope-labeled microspheres, he found that smaller tumors, less than 30 mg in weight, were fed by both the hepatic artery and the portal vein, while larger tumors had a predominant arterial blood supply. In an investigation of 117 patients with primary and secondary carcinoma of the liver, Suzuki et al.

Keywords

Formalin Catheter Ischemia Polyethylene Rubber 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ackerman NB (1974) The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 75: 589–596PubMedGoogle Scholar
  2. 2.
    Almersjö O, Bengmark S, Rudenstam CM, Hafström LO, Nilsson LAV (1972) Evaluation of hepatic dearterialization in primary and secondary cancer of the liver. Am J Surg 124: 5–9PubMedCrossRefGoogle Scholar
  3. 3.
    Almersjö O, Bengmark S, Hafström LO, Leissner KH (1976) Results of liver dearterialization combined with regional infusion of 5-fluorouracil for liver cancer. Acta Chir Scand 142: 131–138PubMedGoogle Scholar
  4. 4.
    Balasegaram M (1972) Complete hepatic dearterialization for primary carcinoma of the liver. Am J Surg 124: 340–345PubMedCrossRefGoogle Scholar
  5. 5.
    Bengmark S, Hafström LO (1965) The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 23: 198–202Google Scholar
  6. 6.
    Bengmark S, Börjesson B, Hafström LO (1971) The natural history of primary carcinoma of the liver. Scand J Gastroenterol 6: 351–355PubMedCrossRefGoogle Scholar
  7. 7.
    Bengmark S, Fredlund P, Hafström LO, VangJ (1974) Present experiences with hepatic dearterialization in liver neoplasms. Prog Surg 13: 141–166Google Scholar
  8. 8.
    Bengtsson G, Carlsson G, Hafström LO, Jönsson PE (1981) Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141: 586–589PubMedCrossRefGoogle Scholar
  9. 9.
    Blanchard RJW, GrotenhuisJ, La FaveJW, PerryJFJr (1965) Blood supply to hepatic Y2 carcinoma implants as measured by radioactive microspheres. Proc Soc Exp Biol Med 118: 465–468Google Scholar
  10. 10.
    BreedisC, YoungG (1954) The blood supply of neoplasms in the liver. Am J Pathol30: 969–986Google Scholar
  11. 11.
    Dahl EP, Fredlund PE, Tylén U, Bengmark S (1981) Transient hepatic dearterialization followed by regional intra-arterial 5-fluorouracil infusion as treatment for liver tumors. Ann Surg 193: 82–88PubMedCrossRefGoogle Scholar
  12. 12.
    El-Domeiri AA, Mojab K (1978) Intermittent occlusion of the hepatic artery and infusion chemotherapy for carcinoma of the liver. Am J Surg 135: 771–775PubMedCrossRefGoogle Scholar
  13. 13.
    FortnerJG, Mulcare RI, Solis A, Watson RC, Colbey RB (1973) Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy. Ann Surg 178: 162–172CrossRefGoogle Scholar
  14. 14.
    Gulessarian HP, Lorton RL, Condon RE (1972) Hepatic artery ligation and cytotoxic infusion in the treatment of liver metastases. Arch Surg 105: 280–285CrossRefGoogle Scholar
  15. 15.
    Jeppsson B, Dahl EP, Fredlund PE, Stenram U, Bengmark S (1979) Hepatic necrosis in the pig produced by transient arterial occlusion. Eur Surg Res 11: 243–253PubMedCrossRefGoogle Scholar
  16. 16.
    Kim DK, Watson RC, Pahnke LD, FortnerJG (1977) Tumor vascularity as a prognostic factor for hepatic tumors. Ann Surg 185: 31–34Google Scholar
  17. 17.
    Lieberman I, ShortJ (1965) Hepatic blood supply and control of deoxyribonucleic acid synthesis in liver. Am J Physiol 208: 896–902Google Scholar
  18. 18.
    McDermott WV, Paris AL, Clouse ME, Meissner WA (1978) Dearterialization of the liver for metastatic cancer. Ann Surg 187: 38–46PubMedCrossRefGoogle Scholar
  19. 19.
    Mokka REM, LarmiTKI, Huttunen R, KairaluomaMl (1975) Evaluation of the ligation of the hepatic artery and regional arterial chemotherapy in the treatment of primary and secondary cancer of the liver. Ann Chir Gynaecol Fenn 64: 347–352Google Scholar
  20. 20.
    Mori W, Masuda M, MiyanagaT (1966) Hepatic artery ligation and tumor necrosis in the liver. Surgery 59: 359–363Google Scholar
  21. 21.
    Nilsson LAV (1966) Therapeutic hepatic artery ligation in patients with secondary liver tumors. Rev Surg 23: 354–363Google Scholar
  22. 22.
    Nilsson LAV, Zettergren L (1967) Blood supply and vascular pattern of induced primary hepatic carcinoma in rats. Acta Pathol Microbiol Scand 71: 179–185PubMedCrossRefGoogle Scholar
  23. 23.
    Ong GB, Chan PKW, AlagaratnamTT (1975) Clinical trials of inoperable primary carcinoma of the liver. Bull Soc Int Chir 5: 391–397Google Scholar
  24. 24.
    Persson B, Andersson L, Jeppsson B, Ekelund L, Strand SE, Bengmark S (1984 a) Development of collateral circulation after repeated transient occlusion of the hepatic artery in pigs. Eur Surg Res 16: 102 (abstr)Google Scholar
  25. 25.
    Persson B, Jeppsson B, Ekelund L, Bengmark S (1984 b) A new device for transient occlusion of the hepatic artery. J Exp Clin Cancer Res 3: 155–160Google Scholar
  26. 26.
    Petrelli NJ, Barcewicz PA, Evans JT, Ledesma EJ, Lawrence DD, Mittelman A (1984) Hepatic artery ligation for liver metastases in colorectal carcinoma. Cancer 53: 1347–1353PubMedCrossRefGoogle Scholar
  27. 27.
    Suzuki T, Sarumaru S, Kawabe K, Honjo I (1972) Study of vascularity of tumors of the liver. Surg Gynaecol Obstet 134: 27–34Google Scholar
  28. 28.
    Takagi H, Morimotu T, Yasue M, Ochiai E, Yamada E, AshikawaT, Kido C (1983) Ligation and catheterization of the hepatic artery for palliative treatment of malignant hepatic tumors. J Surg Oncol 23: 219–222Google Scholar
  29. 29.
    Taylor I (1978) Cytotoxic perfusion for colorectal liver metastases. Br J Surg 65: 109–114PubMedCrossRefGoogle Scholar
  30. 30.
    Wood CB, Gillis CR, Blumgart LH (1976) A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2: 285–288PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1986

Authors and Affiliations

  • S. Bengmark
    • 1
  • B. Jeppsson
    • 1
  1. 1.Department of SurgeryUniversity of LundLundSweden

Personalised recommendations